Las Madrinas Endowment for Experimental Therapeutics for Ophthalmology

Children’s Hospital Los Angeles has been a leader in the treatment of retinoblastoma (Rb), the most common malignant tumor found in the eyes of children. The Las Madrinas Endowment for Experimental Therapeutics for Ophthalmology has supported the important work of Charles Gomer, PhD, from the Children’s Center for Cancer and Blood Diseases.  His most recent study found that targeting the protein survivin enhances the effectiveness of chemotherapy in cells. Dr. Gomer is hopeful that following additional pre-clinical studies about this combination therapy, the research will offer a new option for better outcomes for children with retinoblastoma and perhaps the possibility of reduced chemotherapy, reducing long-term adverse effects. Dr. Gomer thanks Las Madrinas saying that it “continues to be a vital resource for the state-of-the-art research on retinoblastoma that focuses ultimately on improving the lives of patients.”

$2.7 Million Endowment

  • 1997-1999
  • Charles Gomer, PhD